Study to Compare the Pharmacodynamics and Pharmacokinetics of Acetylsalicylic Acid Powder for Oral Inhalation With Non-enteric-coated Chewable Aspirin in Healthy Adults.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 14, 2022

Primary Completion Date

March 9, 2023

Study Completion Date

March 9, 2023

Conditions

Healthy Volunteers

Interventions

DRUG

ASA

powder for oral inhalation via a Dry Powder Inhaler (DPI)

DRUG

non-enteric-coated chewable aspirin

Orally administered

Trial Locations (2)

Sinai Hospital, Baltimore

Bio-Kinetic Clinical Applications, LLC dba QPS-MO, Springfield